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ABSTRACT 
 
Antioxidant-based treatments have emerged as novel and interesting approaches to 
counteract fat accumulation in obesity and associated metabolic disturbances. 
Adipocytes from rats that were fed on chow (C) or high fat diet (HFD) for 50 days, 
were isolated (primary adipocytes) and incubated (72h) on low (LG; 5.6 mM) or high 
(HG; 25 mM) glucose levels, in the presence or absence of 1.6 nM insulin and 200 µM 
vitamin C (VC). Adipocytes from HFD fed animals presented lower insulin-induced 
glucose uptake, lower lactate and glycerol release, and lower insulin-induced secretion 
of some adipokines as compared to controls. HG treatment restored the blunted 
response to insulin regarding apelin secretion in adipocytes from HFD fed rats. VC 
treatment inhibited the levels of nearly all variables, irrespective of the adipocytes’ 
dietary origin. The HG treatment reduced adipocyte viability, and VC protected from 
this toxic effect, although more drastically in control adipocytes. Summing up, in vivo 
chow or HFD intake determines a differential response to insulin and glucose treatments 
that appears to be dependent on the insulin-resistance status of the adipocytes, while VC 
modifies some responses from adipocytes independently of the previous dietary intake 
of the animals. 
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INTRODUCTION 
 
Excessive body fat accumulation can lead to a number of associated clinical 
complications such as type 2 diabetes, metabolic syndrome features, cardiovascular 
diseases and inflammatory disturbances, among others1. These adverse clinical 
manifestations have been linked to impaired production and secretion of endogenous 
products by enlarged adipocytes or the accompanying macrophages from the white 
adipose tissue (WAT) stroma-vascular fraction1. Actually, several adipocytokines and 
inflammatory products derived from this tissue (TNF-α, IL-6, MCP-1, iNOS) have 
shown positive correlations with body adiposity2. Besides the pro-inflammatory 
secretion by WAT, this tissue also produces numerous adipokines that may have 
important local and systemic effects3. Among them, leptin, which has been associated 
with the control of food intake and energy expenditure4, and apelin, which is up-
regulated in obesity and modulated by insulin and TNF-α treatments5,6, are considered 
metabolically relevant. 
On the other hand, mitochondrial dysfunctions and over-production of reactive oxygen 
species (ROS) have been related with obesity7. In this sense, elevated oxidative stress in 
obese patients8 and in overweight animal models9 has been reported. Thus, induced 
monocyte migration to the adipose tissue and high secretion levels of some WAT-
secreted adipokines could be implicated in obesity-associated ROS overproduction9, 
linking the pathogenic secretion pattern of WAT with an enhanced oxidative stress 
status10. 
Furthermore, it has been observed that there is a negative association between higher 
intake of the dietary antioxidant vitamin C (VC) and the occurrence of hypertension, 
gallbladder disease, stroke, cancers and atherosclerosis11, and also with obesity in 
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humans and animals12-14. Among the possible beneficial effects of ascorbic acid on 
obesity-related mechanisms, it has been suggested that this vitamin may: a) modulate 
adipocyte lipolysis15-17, b) regulate the glucocorticoid release from adrenal glands18, c) 
inhibit glucose metabolism and leptin secretion on isolated adipocytes19, d) lead to an 
improvement in hyperglycemia and decrease glycosylation in obese-diabetic mice20, and 
e) reduce the inflammatory response21,22. 
Taking all these findings into account, the present work aimed to analyze whether VC is 
directly implicated in the metabolic response and in the expression/secretion pattern of 
leptin and apelin, two important adipokines, in isolated adipocytes from lean or diet-
induced obese rats, focusing on the possible differential responses of primary 
adipocytes that were isolated from high fat fed animals as compared to control lean 
animals. 
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MATERIALS AND METHODS 
 
Materials 
Dulbecco’s modified eagle’s medium (DMEM), 100X minimal essential medium 
(MEM) non-essential amino acids, penicillin/streptomycin, heat-inactivated fetal bovine 
serum (FBS), 10X MEM, nystatin, Trizol Reagent, and M-MLV reverse transcriptase 
were obtained from Invitrogen (Paisley, UK). Bovine serum albumin (BSA), HEPES, 
insulin and 2′,7′-dichlorofluorescein (DCFH) were all obtained from Sigma-Aldrich 
Company (St. Louis, USA). Collagen (Purecol) was purchased from Nutacon 
(Leimuiden, The Netherlands). Type I collagenase was supplied by Worthington 
Biochemical Corporation (Lakewood, USA), and vitamin C by Panreac Quimica 
(Barcelona, Spain). Glycerol-3-phosphate dehydrogenase (GPDH), glycerol kinase 
(GK), adenosine triphosphate (ATP), and nicotinamide adenine dinucleotide (NAD) 
were obtained from Roche Diagnostics (Mannheim, Germany). 
 
Animals and dietary treatment 
Eight-week-old male Wistar rats (n=20; about 200 g body weight) supplied by the 
Center for Applied Pharmacobiology Research (CIFA, Pamplona, Spain), were housed 
in a temperature-controlled room at 21-23 ºC with a 12 hour light cycle (lights goes off 
at 8 pm). The animals were assigned into two different dietary groups: a control group 
(n=10) that was fed on a standard chow diet (2014 Tekland Global 14 % Protein Rodent 
Maintenance Diet; Harlan Iberica, Barcelona, Spain), and a high fat diet fed group 
(HFD, n=10) that was fed on a high fat diet (D12330 diet, 58 kcal % fat w/cornstarch 
Surwit Diet; Research Diets Inc., New Brunswick, USA) as previously described23. 
Experimental diets detailed composition is described in Table 1. Both groups of animals 
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had ad libitum access to water and food during the trial, and their body weights and 
food intakes were recorded daily. After 50 days of dietary treatment the animals were 
euthanized. The final body weights were recorded, while blood and tissue samples of 
several WAT depots were collected and weighed. About 3-4 g of epididymal WAT was 
immediately isolated from total tissue for adipocyte isolation and primary culture 
experiments. All the procedures were performed according to European, national and 
institutional guidelines of the Animal Care and Use Committee at the University of 
Navarra. 
 
Serum measurements 
Circulating glucose (HK-CP kit; ABX diagnostic, Montpellier, France), total cholesterol 
(Cholesterol CP kit; ABX diagnostic, Montpellier, France), HDL cholesterol (HDL 
Direct CP kit; ABX diagnostic, Montpellier, France), and triglyceride concentrations 
(Triglycerides CP kit; ABX diagnostic, Montpellier, France) were measured using 
automated COBAS MIRA equipment (Roche, Basel, Switzerland). Serum leptin (Linco 
Research, St. Charles, USA), insulin (Mercodia AB, Uppsala, Sweden) and apelin levels 
(Cusabio Biotech Co., Wuhan, China) were determined by different ELISA kits, with an 
automated Triturus equipment (Grifols International, Barcelona, Spain) as described by 
the manufacturers. 
 
Adipocyte isolation 
Primary cultures were obtained according to protocols described elsewhere19. 
Epididymal WAT (3-4 g) of each rat was minced with scissors in HEPES-phosphate 
buffer (pH 7.4; containing 5 mM D-glucose, 2 % w/v BSA, 135 mM NaCl, 2.2 mM 
CaCl2·2H2O, 1.25 mM MgSO4·7H2O, 0.45 mM KH2PO4, 2.17 mM Na2HPO4, and 10 
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mM HEPES). WAT fragments were digested in the same buffer with type I collagenase 
(1.25 mg/ml per 0.5 g tissue) at 37°C with gentle shaking for 30 min. The resulting cell 
suspension was diluted in the buffer, and then the adipocytes were isolated from the 
undigested tissue by filtration through a 400 μm nylon mesh and washed three times 
with alternated centrifugations at 500 rpm for 6 minutes. Isolated adipocytes were then 
resuspended in DMEM supplemented with 1 % v/v FBS, 100 U/ml penicillin / 100 
μg/ml streptomycin, 100 U/ml nystatin and 1X MEM non-essential amino acids, 
followed by incubation for 40 min at 37°C in 5 % CO2. The resulting isolated 
adipocytes (150 μl of a 2:1 mix of packed cells/culture medium) were either used for 
further measurements or plated on 500 μl of a collagen matrix (pH 7; 7 parts collagen : 
1 part 10X MEM) in six well culture plates and cultured at 37 °C / 5 % CO2. 
 
Isolated adipocyte measurements 
Before primary culture, some measures on the isolated adipocytes were performed. In 
the first instance, intracellular ROS concentrations were determined using 2′,7′-
dichlorofluorescein (DCFH) according to a protocol described elsewhere19. Briefly, 
cells were incubated with 10 µM DCFH for 40 minutes in 37 ºC / 5 % CO2, frozen for 
at least 1 h at -80 ºC and then lysed with 500 µl of lysis buffer (150 mM NaCl, 0.1 % 
v/v Triton and 10 mM Tris). Finally, 200 µl of each lysate was plated on a 96-well black 
plate (Labsystems, Barcelona, Spain), and fluorescence intensity was measured with a 
POLARstar spectrofluorometer plate reader (BMG Labtechnologies, Offenburg, 
Germany), at an excitation of 485 nm and an emission of 530 nm. Also, the 
morphological characteristics of the isolated adipocytes were analyzed. Cells were 
placed on a Neubauer chamber and coupled on an Olympus CK30 microscope 
(Olympus Corporation, Barcelona, Spain). Then, pictures were taken with an Olympus 
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C-5060WZ Digital Camera (Olympus Corporation, Barcelona, Spain) using a Camedia 
Adapter C5060-ADUS for IUS Microscope (Olympus Corporation, Barcelona, Spain) at 
40X magnification. Pictures in TIFF format with 400x300 pixels resolution were 
processed with the Scion Image for Windows software (Scion Corporation, Maryland, 
USA) for cell number and diameter determinations. Finally, mRNA expressions of 
apelin and leptin in these isolated adipocytes were also measured according to the 
protocol described below (gene expression assays section). 
 
Adipocytes culture 
After the final 40-50 min incubation, the adipocytes were treated with high (HG, 25 
mM; n=5) and low (LG, 5.6 mM; n=5) glucose concentrations, in the presence or 
absence of 1.6 nM insulin and 200 µM vitamin C (VC). Cells were maintained in an 
incubator at 37°C in 5 % CO2. Aliquots of the culture medium and culture plates were 
collected at 72 h and frozen at -80 ºC for further assays. 
 
Cell viability assay 
The lactate dehydrogenase (LDH) activity (μU/ml) in culture medium is commonly 
used as an indicator of cell membrane integrity, as well as a measurement of cellular 
necrosis/apoptosis24. Cell viability was measured with the LDH Cytotoxicity Assay Kit 
according to the supplier’s instructions (Cayman Chemical Company, Ann Arbor, 
USA), and was assessed at the end of the experimental period (72 h) in all treatments. 
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Culture medium determinations 
Glucose utilization was assessed by measuring the concentration of glucose in the 
medium in each well at 72 h, and then subtracting it from the initial concentration. 
Lactate production was calculated as the increase of lactate in the medium at 72 h. 
Glucose and lactate concentrations were measured with the HK-CP kit from ABX 
diagnostic (Montpellier, France) and with the L-lactate kit from Randox Laboratories 
(Crumlin, UK), respectively, using an automated COBAS MIRA equipment (Roche, 
Basel, Switzerland). Glycerol concentration increase in the medium at 72 h, as a 
measure of the lipolytic activity, was determined by a colorimetric method as previously 
published25. Briefly, culture media of each sample were incubated with 25 μg/ml GPDH 
and 250 mU/ml GK, in the presence of 43.6 mM MgCl2, 200 mM glycine, 5.2 % v/v 
hydrazine, 1.24 mM ATP and 573 μM NAD for 40 minutes. Finally, absorbance of the 
samples was measured at 340 nm in a microplate reader (Multiskan Spectrum, Thermo 
Fisher Scientific, Waltham, USA). Finally, leptin (sensitivity ≥ 0.04 ng/mL; intra-assay 
precision ± 2.17 % CV; inter-assay precision ± 3.40 % CV) and apelin (sensitivity ≥ 3.9 
pg/ml; intra-assay precision < 8 % CV; inter-assay precision < 10 % CV) secretions at 
72 h were determined by the ELISA kits as previously indicated in the serum 
measurements section. All culture medium determinations were corrected for cell 
viability22. 
 
Gene expression assays 
Total RNA was isolated from isolated epididymal adipocytes using Trizol (Invitrogen, 
Paisley, UK) according to the manufacturer’s protocol. Purified total RNA from 
adipocytes was treated with DNAse (DNAfree kit; Ambion Inc., Austin, USA) and used 
to generate cDNA with M-MLV reverse transcriptase (Invitrogen, Paisley, UK). 
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Relative real-time PCR was performed on an ABI PRISM 7000 HT Sequence Detection 
System (Applied Biosystems, California, USA). Taqman probes for rat leptin, apelin 
and 18S rRNA, were also supplied by Applied Biosystems (California, USA). 
Expression levels were normalized by the mRNA levels of the selected internal control, 
18S. All procedures were performed according to protocols described elsewhere19. 
 
Statistical analyses 
Student t tests were used for analyzing differences among experimental groups, either 
for body and biochemical variables of animals, and for measurements performed in 
isolated adipocytes from rats that were obtained before the primary culture (n=10), or 
for measurements performed directly on the primary cultures (n=5). On primary 
cultures, after one-way ANOVA, multiple comparisons using t-student tests were 
performed at three stages: 1) comparison against control group (without HFD, VC, 
insulin or HG treatment), 2) comparison against HFD treated group (without VC, 
insulin or HG treatment), and 3) comparison against HG treated group (without VC or 
insulin treatment). For correlation analyses, Pearson correlation coefficients were 
calculated. All results are expressed as means ± SD. A probability of p<0.05 was set for 
determining statistically significant differences. All the analyses were performed using 
the SPSS 15.0 for Windows software (SPSS Inc., Chicago, USA). 
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RESULTS 
 
High fat diet-induced obesity 
The high fat dietary treatment effectively induced overweight in the animals. Thus, 
HFD treatment induced elevated body and WAT weights, and higher levels of some 
biochemical blood markers, such as glucose, insulin, and leptin, as compared to rats fed 
on the chow diet (Table 2). Also, adipocytes isolated from epididymal WAT of HFD-
fed rats presented different morphological and functional characteristics as compared to 
controls, such as higher cell diameter and intracellular ROS content, higher apelin and 
leptin gene expression and lower cell number per suspension volume (ml) (Table 2). 
 
Viability assay 
LDH activity in culture medium after the 72 h treatment was measured as an indicator 
of cell viability (Figure 1; one-way ANOVA, p<0.001). Cell viability was drastically 
reduced in adipocytes by HG addition, from both control and HFD treated animals, 
although more drastically in control adipocytes. This effect was completely reversed by 
the addition of VC into the culture media. 
 
Glucose and lipid metabolism 
The glucose uptake, lactate production and glycerol release of adipocytes isolated from 
epididymal WAT of rats after the 72 h culture were measured (Figure 2). No important 
effects of HFD treatment on glucose uptake were observed (Figure 2A; one-way 
ANOVA, p<0.01). However, insulin treatment, as expected, induced higher glucose 
uptake, but only in control adipocytes without HG treatment. Although a slight effect of 
VC was observed, it was only statistically significant in adipocytes from HFD rats. 
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Regarding lactate production (Figure 2B; one-way ANOVA, p<0.001), insulin induced 
higher release of this metabolite again only in control adipocytes. This induction was 
not observed under HG or HFD treatment. On the other hand, VC exerts inhibitory 
effects in almost all experimental conditions. A slight decrease was observed in 
adipocytes from HFD fed animals as compared to controls, however without reaching 
statistical significance (p=0.052). 
Finally, glycerol release was generally reduced in adipocytes from HFD fed rats, and 
drastically inhibited by VC treatment, especially in primary adipocytes from control 
animals. 
 
Adipokines mRNA expression 
The mRNA expression of apelin and leptin was also analyzed in the primary cultures 
(Figure 3). Concerning apelin mRNA expression (Figure 3A; one-way ANOVA, 
p<0.001), no effects of HFD and insulin treatments were observed. VC induced 
decreased apelin expression, especially in those that were not treated with HG. HG 
treatment induced a slight reducing effect only in adipocytes from HFD rats (p=0.094). 
Regarding leptin mRNA expression levels (Figure 3B; one-way ANOVA, p<0.001), 
statistical tendencies towards higher expression induced by insulin (p=0.068) and HG 
(p=0.059) treatments were only observed in controls. VC treatment induced slight 
inhibitions in leptin gene expression, only statistically significant in cells under insulin 
and HG treatment. 
 
Adipokine secretion 
The secretion of apelin and leptin gene products after 72 h of culture was also measured 
(Figure 4). Insulin treatment induced a statistically significant increase in apelin 
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secretion only in control adipocytes (Figure 4A; one-way ANOVA, p<0.001). On the 
other hand, HFD treatment induced lower apelin secretion, and HG provoked higher 
adipokine release, but only in adipocytes from HFD rats. VC treatment overall produced 
lower apelin secretion, an effect that was particularly significant in control adipocytes. 
Leptin secretion was significantly induced by insulin only in control adipocytes, 
regardless of glucose treatment (Figure 4B; one-way ANOVA, p<0.001). HG per se 
induced higher leptin secretion, while VC only inhibited this adipokine in the presence 
of HG, an effect that was once again only seen in control adipocytes. These effects were 
blunted in adipocytes from HFD rats. 
 
Association studies 
Correlation analyses among some in vivo and ex vivo measurements were performed 
(Figure 5). Among variables measured prior to cell culture procedures, intracellular 
ROS content of adipocytes correlated positively with retroperitoneal WAT weight (r = 
0.673, p<0.01), mesenteric WAT weight (r = 0.561, p<0.05), serum leptin concentration 
(r = 0.610, p<0.05), and leptin gene expression in adipocytes (r = 0.692, p<0.01). On the 
other hand, glucose uptake measured after 72 h of adipocyte culture correlated 
negatively with several variables measured before culture, such as animal body (r = -
0.387, p<0.01), epididymal (r = -0.316, p<0.01), subcutaneous (r = -0.259, p<0.05), 
retroperitoneal (r = -0.398, p<0.001), mesenteric (r = -0.354, p<0.01) and total fat depot 
(r = - 0.358, p<0.01) weights, blood glucose levels (r = -0.230, p<0.05) and adipocyte 
cell diameter (r = -0.362, p<0.01). Finally, adipocyte apelin gene expression after 72 
hours culture correlated positively with rat epididymal fat depot weight (r = 0.327, 
p<0.01) and insulin blood levels (r = 0.336, p<0.01). 
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DISCUSSION 
 
The scientific literature describes controversial results for a potential role of 
antioxidants in obesity prevention or treatment26. Nevertheless, the health-improving 
effects of VC treatment on body weight and waist-hip ratio, cardiovascular disease 
occurrence, and on glucose and lipid biomarkers in humans14,27-29 and animals20, have 
been reported. In the present work, some obesity-related variables of adipocytes isolated 
from obese animals were compared with control adipocytes under VC treatment and 
subjected to several experimental conditions. 
The HFD fed animals presented all features of an obesity-established state. Moreover, 
the associations observed between intracellular ROS in adipocytes and several obesity-
related variables agree with the previous literature, which reported higher oxidative 
stress in excessively enlarged adipose tissue. This is an important trigger for the onset of 
obesity-related metabolic syndrome features9. In culture, the onset of insulin resistance 
is suggested by the fact that lactate release was lower, and that the insulin treatment did 
not induce higher glucose uptake, lactate production and adipokine release of adipocytes 
from HFD rats23, ,30 31. In addition, this observation is supported with the negative 
correlations observed between adipocyte glucose uptake and several obesity-related 
variables, and with the positive correlations observed between apelin mRNA expression 
of adipocytes after culture, with WAT weight and blood insulin. On the contrary, lower 
serum triglycerides levels in HFD fed animals with respect to controls were found. 
Nevertheless, this result agrees with a previous report performed in the same obesity 
model32. In this study, higher liver triglyceride contents were detected in HFD-fed rats, 
indicating that this metabolite, at this stage, could be rapidly mobilized to the liver, 
possibly leading to steatosis. Concerning the higher HDL cholesterol content in HFD 
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fed animals, despite the fact that dietary saturated fat intake has been associated with 
increased plasma cholesterol (particularly LDL), paradoxically, saturated fat intake has 
also been related with elevated HDLc plasma levels33. In this regard, it has been 
observed that low saturated fat and cholesterol intake reduced apolipoprotein A1 
secretion34. 
Regarding VC treatment, first of all, it is worth mentioning that the dose used had been 
previously utilized by our research group, and it was described that it is within 
physiological levels19. The facts that insulin-induced adipocytes presented basal glucose 
uptake levels, and that VC treatment directly inhibits the glucose uptake in adipocytes 
from HFD animals, agrees with a previous report19. Indeed, it is known that the 
dehydroascorbic acid (the oxidized form of VC that is transported inside cells) could 
compete with glucose for GLUT-1 and GLUT-4 transporters35,36. The drastic inhibition 
in lactate production by this vitamin, which was observed in adipocytes from both 
types, is in accordance with a study describing a lactic acid plasma concentration 
reduction of dietary feeds by a vitamin C/E treatment in diabetic rats37, and again, with 
a previous report that was performed in adipocytes from lean animals19. The present 
work suggests that the effect of this vitamin is independent of the dietary origin of the 
cells. On the other hand, in muscle cells, a H2O2 treatment induces glucose uptake, 
lactate production and the gene expression of proteins involved in glucose metabolism. 
However, treatment with the antioxidant n-acetylcysteine reduced the ROS content, 
glucose uptake, lactate production, the expression of GLUT4, and the PFK activity38. It 
was suggested that the reducing properties of n-acetylcysteine on glucose uptake are 
attributed to its ROS scavenger properties. In this context, VC could also induce glucose 
uptake inhibition by its well-known ROS scavenging properties35,39. 
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With regard to lipolytic activity, the lower glycerol release of adipocytes from HFD-fed 
rats could be due to a fat hydrolysis resistance40,41. On the other hand, despite the fact 
that the results did not replicate the well-known antilipolytic effects of insulin42, these 
are in agreement with other reports19,43, indicating a lack of lipolysis modulation by 
insulin in this experimental model. Also, it is worth mentioning that the antilipolytic 
effects of insulin are blunted in visceral compared to subcutaneous adipocytes44. 
Finally, the lower glycerol release induced by VC indicates an inhibited fat utilization 
on both insulin-treated and non-treated adipocytes from chow or HFD-fed rats. It has 
been described that rats fed on HFD with VC supplementation presented a decreased 
isoproterenol-induced lipolysis as compared with the rats that were fed with high fat 
diet alone15, and that VC inhibited glycerol release in primary cultured adipocytes from 
lean animals19. Furthermore, the lower lipolysis is in agreement with a possible insulin-
sensitizing property of VC13, ,15 29. 
Regarding apelin and leptin expression and secretion, at first glance, no positive 
correlations between the expression pattern and the secretion levels of both adipokines 
were observed. This outcome could be explained by possible mRNA expression 
fluctuations during culture and by probable post-transcriptional events45,46. As 
mentioned before, the lower apelin and leptin secretion response to insulin in adipocytes 
from HFD-fed rats could be attributed to the insulin-resistant state of these adipocytes23. 
It is important to notice, that this effect was overcome by the HG treatment especially in 
the apelin secretion, which agrees with a previous report47. Leptin production appears to 
be more blunted by the HFD treatment. With respect to the effects of VC, the results are 
consistent with a previously described inhibition of apelin expression and leptin 
expression/secretion in WAT from rats that were fed on a high fat diet supplemented 
with VC13. The present work confirms a direct effect of VC treatment in adipocytes that 
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were isolated from rat visceral fat. These data show that the VC treatment leads to 
important secretion alterations independent of the dietary origin of the adipocytes. The 
VC inhibitory effects on leptin secretion are in accordance with a study describing 
direct inhibitory effects in adipocytes isolated from lean rats19. Similar results were 
observed with other antioxidant substances, such as resveratrol and lipoic acid48,49. 
Regarding the possible mechanisms that could have lead to the observed results, it has 
been reported that a VC treatment reduced the hypoxia-inducible factor 1α (HIF-1α) 
expression in rat prostate50, factor which is known to induce apelin gene expression51. 
Also, it has been reported that insulin and hypoxia, through HIF-1α, act as agonists of 
leptin transcription in BeWo cells52. Moreover, both genes present insulin-response 
elements in their promoters53,54, and both transcripts could be affected by ROS 
content55. 
A toxic effect of  HG incubation was observed in the current experiments, as was 
reported previously in the same experimental model56. Although it has been previously 
described that an in vivo VC treatment reduced adipocyte cell number17, no negative 
effects on ex vivo cell viability of this vitamin were detected. In fact, we observed a 
protective effect for this molecule against HG toxicity. This finding could be due to 
competition with glucose for GLUT-1, and -4 transporters35,36, reducing the effects of 
glucose on the hexosamine flux pathway57. Consequently, this situation could avoid cell 
death in control cells and possibly improve insulin sensitivity, since glucose toxicity 
contributes to insulin-resistance58. In this context, it has previously been found that 
antioxidant treatments reduce glucose toxicity in pancreatic β cells (HIT-T15) as well as 
in Zucker diabetic obese rats59, and that cells under HG treatment present augmented 
ROS intracellular content and suffer mitochondrial dysfunction60. Finally, this could 
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explain the relatively lower effect of VC on adipocytes from HFD animals, since these 
cells presented higher ROS content prior to culture. 
In summary, adipocytes isolated from the epididymal fat of rats, which were fed on 
either a chow or high fat diet, presented different responses to glucose and insulin 
incubations. Animals in each group displayed differences in their levels of glucose and 
lipid metabolism markers, as well as in their expression/secretion pattern of apelin and 
leptin in primary culture, due to the establishment of an insulin-resistant state in animals 
fed on HFD. Furthermore, vitamin C incubation in this culture leads to dramatic 
modifications of these variables, although these effects appear to be independent of the 
dietary origin of the adipocytes. Indeed, primary adipocytes from animals fed on HFD 
diet show impairment in metabolic functions concerning glucose and lipid metabolism 
as compared to chow fed animals, while the response to VC appears to be inhibitory in 
both dietary groups. 
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FIGURE LEGENDS 
 
Figure 1. Viability assay of the primary culture. The effects of 200 µM vitamin C, 1.6 
nM insulin, and high (25 mM) or low (5.6 mM) glucose concentrations on 72 h lactate 
dehydrogenase activity in culture medium of isolated adipocytes from chow (white 
bars) of high fat diet (black bars) fed rats are shown. Data (n = 5) are expressed as 
median ± SD. ***p<0.001 indicates differences against control group; †p<0.05 against 
HFD treated-only group; §p<0.05, §§p<0.01 and §§§p<0.001 against each (control and 
HFD) HG treated group. HF, high fat; VC, vitamin C; INS, insulin; HG, high glucose. 
 
Figure 2. Glucose and lipid metabolism measurements in the primary culture. The 
effects of 200 µM vitamin C, 1.6 nM insulin, and high (25 mM) or low (5.6 mM) 
glucose concentrations on 72 h (A) glucose uptake, (B) lactate production, and (C) 
glycerol release of isolated adipocytes from chow (white bars) of high fat diet (black 
bars) fed rats are shown. Data (n = 5) are expressed as median ± SD. *p<0.05 and 
**p<0.01 indicate differences against control group; †p<0.05 against HFD treated-only 
group; §p<0.05 against each (control and HFD) HG treated group. HF, high fat; VC, 
vitamin C; INS, insulin; HG, high glucose; t*, statistical tendency. 
 
Figure 3. Adipokines gene expression measurements in the primary culture. The effects 
of 200 µM vitamin C, 1.6 nM insulin, and high (25 mM) or low (5.6 mM) glucose 
concentrations on 72 h (A) apelin, and (B) leptin mRNA expression of isolated 
adipocytes from chow (white bars) of high fat diet (black bars) fed rats are shown. Data 
(n = 5) are expressed as median ± SD. *p<0.05 indicates differences against control 
group; ††p<0.01 against HFD treated-only group; §p<0.05 against each (control and 
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HFD) HG treated group. HF, high fat; VC, vitamin C; INS, insulin; HG, high glucose; 
t*, statistical tendency. 
 
Figure 4. Adipokines secretion measurements in the primary culture. The effects of 200 
µM vitamin C, 1.6 nM insulin, and high (25 mM) or low (5.6 mM) glucose 
concentrations on 72 h (A) apelin, and (B) leptin secretion to culture medium of isolated 
adipocytes from chow (white bars) of high fat diet (black bars) fed rats are shown. Data 
(n = 5) are expressed as median ± SD. *p<0.05, **p<0.01 and ***p<0.001 indicate 
differences against control group; ††p<0.01 against HFD treated-only group; §p<0.05 
and §§p<0.01 against each (control and HFD) HG treated group. HF, high fat; VC, 
vitamin C; INS, insulin; HG, high glucose; t*, statistical tendency. 
 
Figure 5. Association analyses between intracellular ROS content prior to cell culture 
and (A) retroperitoneal WAT weight, (B) mesenteric WAT weight, (C) serum leptin and 
(D) adipocyte leptin gene expression prior to cell culture, between glucose uptake after 
cell culture and (E) final body weight, (F) total fat weight, (G) serum glucose and (H) 
adipose cell diameter prior to cell culture, and between apelin gene expression after cell 
culture and (I) epididymal WAT weight and (J) serum insulin. Triangles represent 
control fed animals and closed circles represent HFD fed animals. AU, arbitrary units, 
FI, fluorescence intensity; WAT, white adipose tissue; r, Pearson’s correlation 
coefficient. 
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